Your browser doesn't support javascript.
loading
Long-term renin-angiotensin blocking therapy in hypertensive patients with normal aorta may attenuate the formation of abdominal aortic aneurysms.
Silverberg, Daniel; Younis, Anan; Savion, Naphtali; Harari, Gil; Yakubovitch, Dmitry; Sheick Yousif, Basheer; Halak, Moshe; Grossman, Ehud; Schneiderman, Jacob.
Afiliación
  • Silverberg D; The Department of Vascular Surgery, Sheba Medical Center, Tel Hashomer, Israel.
  • Younis A; The Department of Internal Medicine D and Hypertension Clinic, Sheba Medical Center, Tel Hashomer, Israel.
  • Savion N; The Goldschleger Eye Research Institute, Sackler Faculty of Medicine, Tel Aviv University, Tel Hashomer, Israel.
  • Harari G; Medistat Ltd. Tel Aviv, Israel.
  • Yakubovitch D; The Department of Vascular Surgery, Sheba Medical Center, Tel Hashomer, Israel.
  • Sheick Yousif B; The Department of Vascular Surgery, Sheba Medical Center, Tel Hashomer, Israel.
  • Halak M; The Department of Vascular Surgery, Sheba Medical Center, Tel Hashomer, Israel.
  • Grossman E; The Department of Internal Medicine D and Hypertension Clinic, Sheba Medical Center, Tel Hashomer, Israel.
  • Schneiderman J; The Department of Vascular Surgery, Sheba Medical Center, Tel Hashomer, Israel; The Gottesdiener Vascular Biology Laboratory, Sackler Faculty of Medicine, Tel Aviv University, Tel Hashomer, Israel. Electronic address: jschneid72@yahoo.com.
J Am Soc Hypertens ; 8(8): 571-7, 2014 Aug.
Article en En | MEDLINE | ID: mdl-24913570
Renin-angiotensin system (RAS) has been implicated in the pathogenesis of abdominal aortic aneurysm (AAA). Angiotensin II type 1 receptor blocker (ARB), when given with angiotensin II prevents AAA formation in mice, but found ineffective in attenuating the progression of preexisting AAA. This study was designed to evaluate the effect of chronic RAS blockers on abdominal aortic diameter in hypertensive patients without known aortic aneurysm. Consecutive hypertensive outpatients (n = 122) were stratified according to antihypertensive therapy they received for 12 months or more, consisting of ARB (n = 45), angiotensin converting enzyme inhibitor (ACE-I; n = 45), or nonARB/nonACE-I (control therapy; n = 32). Abdominal ultrasonography was performed to measure maximal subrenal aortic diameter. Eighty-four patients were reexamined by ultrasonography 8 months later. The correlation between the different antihypertensive therapies and aortic diameter was examined. Aortic diameters were significantly smaller in ARB than in control patients in the baseline and follow-up measurements (P = .004; P = .0004, respectively). Risk factor adjusted covariance analysis showed significant differences between ARB or ACE-I treated groups and controls (P = .006 or P = .046, respectively). Ultrasound that was performed 8 months later showed smaller increases in mean aortic diameters of the ARB and ACE-I groups than in controls. Both ARB and ACE-I therapy attenuated expansion of nonaneurysmal abdominal aorta in humans. These results indicate that RAS blockade given before advancement of aortic medial remodeling may slow down the development of AAA.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Inhibidores de la Enzima Convertidora de Angiotensina / Aneurisma de la Aorta Abdominal / Bloqueadores del Receptor Tipo 1 de Angiotensina II / Remodelación Vascular / Hipertensión Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male Idioma: En Revista: J Am Soc Hypertens Asunto de la revista: ANGIOLOGIA / CARDIOLOGIA Año: 2014 Tipo del documento: Article País de afiliación: Israel Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Inhibidores de la Enzima Convertidora de Angiotensina / Aneurisma de la Aorta Abdominal / Bloqueadores del Receptor Tipo 1 de Angiotensina II / Remodelación Vascular / Hipertensión Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male Idioma: En Revista: J Am Soc Hypertens Asunto de la revista: ANGIOLOGIA / CARDIOLOGIA Año: 2014 Tipo del documento: Article País de afiliación: Israel Pais de publicación: Estados Unidos